Anti-cancer DC Cell Vaccination to Treat Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

December 30, 2030

Study Completion Date

December 30, 2035

Conditions
Solid Tumor, AdultDC
Interventions
BIOLOGICAL

DC cell Vaccine

Deliver DC cell vaccine into patients for anti-ancer therapy.

Trial Locations (1)

51260

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guanzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER